Association between omental adipose tissue macrophages and liver histopathology in morbid obesity: Influence of glycemic status

Journal of Hepatology

Volumn 51, Issue 2, 2009, Pages 354-362

  Tordjman, Joan ^a,b   Poitou, Christine ^a,b,c   Hugol, Danielle ^d   Bouillot, Jean Luc ^d   Basdevant, Arnaud ^a,b,c   Bedossa, Pierre ^e,f   Guerre Millo, Michèle ^a,b   Clement, Karine ^a,b,c  

^a CENTRE DE RECHERCHE DES CORDELIERS   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d HÔTEL DIEU   (France)

^e BEAUJON HOSPITAL   (France)

^f CENTRE DE RECHERCHE BIOMÉDICALE BICHAT BEAUJON CRB3   (France)

Author keywords

Adipose tissue; Inflammation; Macrophages; Metabolic diseases; NAFLD; Obesity

Indexed keywords

ANTILIPEMIC AGENT; FIBRIC ACID DERIVATIVE; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; METFORMIN;

ADIPOSE TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; FATTY LIVER; FEMALE; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATION; INSULIN RESISTANCE; LIVER FIBROSIS; LIVER HISTOLOGY; LIVER INJURY; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; OBESITY; OMENTUM; PRIORITY JOURNAL; STOMACH BYPASS;

ABDOMINAL FAT; ADULT; BLOOD GLUCOSE; CELL COUNT; DIABETES MELLITUS, TYPE 2; FATTY LIVER; FEMALE; HUMANS; INSULIN RESISTANCE; LIVER; LIVER CIRRHOSIS; MACROPHAGES; MALE; OBESITY, MORBID; OMENTUM;

EID: 67649380355     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2009.02.031     Document Type: Article

References (33)

1. Xu H., Barnes G.T., Yang Q., Tan G., Yang D., Chou C.J., et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112 (2003) 1821-1830
2. Weisberg S.P., McCann D., Desai M., Rosenbaum M., Leibel R.L., Ferrante A.W., et al. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112 (2003) 1796-1808
3. Curat C.A., Miranville A., Sengenes C., Diehl M., Tonus C., Busse R., et al. From blood monocytes to adipose tissue-resident macrophages: induction of diapedesis by human mature adipocytes. Diabetes 53 (2004) 1285-1292
4. Cancello R., Henegar C., Viguerie N., Taleb S., Poitou C., Rouault C., et al. Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes 54 (2005) 2277-2286
5. Kanda H., Tateya S., Tamori Y., Kotani K., Hiasa K., Kitazawa R., et al. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest 116 (2006) 1494-1505
6. Weisberg S.P., Hunter D., Huber R., Lemieux J., Slaymaker S., Vaddi K., et al. CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J Clin Invest 116 (2006) 115-124
7. Kamei N., Tobe K., Suzuki R., Ohsugi M., Watanabe T., Kubota N., et al. Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance. J Biol Chem 281 (2006) 26602-26614
8. Cancello R., Tordjman J., Poitou C., Guilhem G., Bouillot J.L., Hugol D., et al. Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity. Diabetes 55 (2006) 1554-1561
9. Utzschneider K.M., and Kahn S.E. Review: the role of insulin resistance in nonalcoholic fatty liver disease. J Clin Endocrinol Metab 91 (2006) 4753-4761
10. Rector R.S., Thyfault J.P., Wei Y., and Ibdah J.A. Non-alcoholic fatty liver disease and the metabolic syndrome: an update. World J Gastroenterol 14 (2008) 185-192
11. Fontana L., Eagon J.C., Trujillo M.E., Scherer P.E., and Klein S. Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes 56 (2007) 1010-1013
12. Kotronen A., Westerbacka J., Bergholm R., Pietilainen K.H., and Yki-Jarvinen H. Liver fat in the metabolic syndrome. J Clin Endocrinol Metab 92 (2007) 3490-3497
13. Kotronen A., and Yki-Jarvinen H. Fatty liver: a novel component of the metabolic syndrome. Arterioscler Thromb Vasc Biol 28 (2008) 27-38
14. Poitou C., Coupaye M., Laaban J.P., Coussieu C., Bedel J.F., Bouillot J.L., et al. Serum amyloid A and obstructive sleep apnea syndrome before and after surgically-induced weight loss in morbidly obese subjects. Obes Surg 16 (2006) 1475-1481
15. Mutch D.M., Tordjman J., Pelloux V., Hanczar B., Henegar C., Poitou C., et al. Needle and surgical biopsy techniques differentially affect adipose tissue gene expression profiles. Am J Clin Nutr 89 (2009) 51-57
16. Brunt E.M., Janney C.G., Di Bisceglie A.M., Neuschwander-Tetri B.A., and Bacon B.R. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 94 (1999) 2467-2474
17. Kleiner D.E., Brunt E.M., Van Natta M., Behling C., Contos M.J., Cummings O.W., et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41 (2005) 1313-1321
18. Katz A., Nambi S.S., Mather K., Baron A.D., Follmann D.A., Sullivan G., et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85 (2000) 2402-2410
19. Clement K., Lahlou N., Ruiz J., Hager J., Bougneres P., Basdevant A., et al. Association of poorly controlled diabetes with low serum leptin in morbid obesity. Int J Obes Relat Metab Disord 21 (1997) 556-561
20. Guerre-Millo M. Adiponectin: an update. Diabetes Metab 34 (2008) 12-18
21. Klein S., Mittendorfer B., Eagon J.C., Patterson B., Grant L., Feirt N., et al. Gastric bypass surgery improves metabolic and hepatic abnormalities associated with nonalcoholic fatty liver disease. Gastroenterology 130 (2006) 1564-1572
22. Ratziu V., Giral P., Jacqueminet S., Charlotte F., Hartemann-Heurtier A., Serfaty L., et al. Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) Trial. Gastroenterology 135 (2008) 100-110
23. Kolak M., Westerbacka J., Velagapudi V.R., Wagsater D., Yetukuri L., Makkonen J., et al. Adipose tissue inflammation and increased ceramide content characterize subjects with high liver fat content independent of obesity. Diabetes 56 (2007) 1960-1968
24. van der Poorten D., Milner K.L., Hui J., Hodge A., Trenell M.I., Kench J.G., et al. Visceral fat: a key mediator of steatohepatitis in metabolic liver disease. Hepatology 48 (2008) 449-457
25. Di Gregorio G.B., Yao-Borengasser A., Rasouli N., Varma V., Lu T., Miles L.M., et al. Expression of CD68 and macrophage chemoattractant protein-1 genes in human adipose and muscle tissues: association with cytokine expression, insulin resistance, and reduction by pioglitazone. Diabetes 54 (2005) 2305-2313
26. Makkonen J., Westerbacka J., Kolak M., Sutinen J., Corner A., Hamsten A., et al. Increased expression of the macrophage markers and of 11beta-HSD-1 in subcutaneous adipose tissue, but not in cultured monocyte-derived macrophages, is associated with liver fat in human obesity. Int J Obes (Lond) 31 (2007) 1617-1625
27. Apovian C.M., Bigornia S., Mott M., Meyers M.R., Ulloor J., Gagua M., et al. Adipose macrophage infiltration is associated with insulin resistance and vascular endothelial dysfunction in obese subjects. Arterioscler Thromb Vasc Biol 28 (2008) 1654-1659
28. Charles M.A., Eschwege E., and Basdevant A. Monitoring the obesity epidemic in france: the obepi surveys 1997-2006. Obesity (Silver Spring) 16 (2008) 2182-2186
29. Chen H., Sullivan G., Yue L.Q., Katz A., and Quon M.J. QUICKI is a useful index of insulin sensitivity in subjects with hypertension. Am J Physiol Endocrinol Metab 284 (2003) E804-E812
30. Yokoyama H., Emoto M., Fujiwara S., Motoyama K., Morioka T., Komatsu M., et al. Quantitative insulin sensitivity check index and the reciprocal index of homeostasis model assessment in normal range weight and moderately obese type 2 diabetic patients. Diabetes Care 26 (2003) 2426-2432
31. Rabasa-Lhoret R., Bastard J.P., Jan V., Ducluzeau P.H., Andreelli F., Guebre F., et al. Modified quantitative insulin sensitivity check index is better correlated to hyperinsulinemic glucose clamp than other fasting-based index of insulin sensitivity in different insulin-resistant states. J Clin Endocrinol Metab 88 (2003) 4917-4923
32. Suganami T., Nishida J., and Ogawa Y. A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor alpha. Arterioscler Thromb Vasc Biol 25 (2005) 2062-2068
33. Permana P.A., Menge C., and Reaven P.D. Macrophage-secreted factors induce adipocyte inflammation and insulin resistance. Biochem Biophys Res Commun 341 (2006) 507-514